SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Batra Sandeep

(Last)

(First)

(Middle)

ICICI BANK TOWERS, BANDRA-KURLA COMPLEX

(Street)

MUMBAI

400051

(City)

(State)

(Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICICI BANK LTD [ IBN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares, par value Rs. 2 per share	809,435	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	⁽¹⁾	Equity Shares, par value Rs. 2 per share	198,190⁽²⁾	$14.67⁽³⁾	D
Stock Option (Right to Buy)	⁽⁴⁾	⁽⁴⁾	Equity Shares, par value Rs. 2 per share	196,000⁽²⁾	$12.04⁽³⁾	D
Stock Option (Right to Buy)	⁽⁵⁾	⁽⁵⁾	Equity Shares, par value Rs. 2 per share	231,000⁽²⁾	$9.67⁽³⁾	D
Stock Option (Right to Buy)	⁽⁶⁾	⁽⁶⁾	Equity Shares, par value Rs. 2 per share	249,100⁽²⁾	$8.09⁽³⁾	D
Stock Option (Right to Buy)	⁽⁷⁾	⁽⁷⁾	Equity Shares, par value Rs. 2 per share	305,350⁽²⁾	$6.16⁽³⁾	D
Stock Option (Right to Buy)	⁽⁸⁾	⁽⁸⁾	Equity Shares, par value Rs. 2 per share	427,350⁽²⁾	$3.65⁽³⁾	D
Stock Option (Right to Buy)	⁽⁹⁾	⁽⁹⁾	Equity Shares, par value Rs. 2 per share	179,800⁽²⁾	$4.35⁽³⁾	D
Stock Option (Right to Buy)	⁽¹⁰⁾	⁽¹⁰⁾	Equity Shares, par value Rs. 2 per share	202,125⁽²⁾	$2.71⁽³⁾	D
Stock Option (Right to Buy)	⁽¹¹⁾	⁽¹¹⁾	Equity Shares, par value Rs. 2 per share	256,025⁽²⁾	$2.4⁽³⁾	D
Stock Option (Right to Buy)	⁽¹²⁾	⁽¹²⁾	Equity Shares, par value Rs. 2 per share	404,250⁽²⁾	$2.64⁽³⁾	D
Stock Option (Right to Buy)	⁽¹³⁾	⁽¹³⁾	Equity Shares, par value Rs. 2 per share	188,650⁽²⁾	$3.03⁽³⁾	D
Stock Option (Right to Buy)	⁽¹⁴⁾	⁽¹⁴⁾	Equity Shares, par value Rs. 2 per share	107,800⁽²⁾	$2.56⁽³⁾	D
Stock Option (Right to Buy)	⁽¹⁵⁾	⁽¹⁵⁾	Equity Shares, par value Rs. 2 per share	70,125⁽²⁾	$2.31⁽³⁾	D

Explanation of Responses:

1. A total of 198,190 stock options granted on April 17, 2025 and vesting in three tranches: (i) 59,457 vesting on April 17, 2026 and expiring on April 16, 2031, (ii) 59,457 vesting on April 17, 2027 and expiring on April 16, 2032, and (iii) 79,276 vesting on April 17, 2028 and expiring on April 16, 2033.

2. Each stock option represents the contingent right to apply for one Equity Share.

3. The exercise prices of the stock options are denominated in Rupee and translated for convenience only into USD at the rate of INR92.47 to US$1.00, the exchange rate set forth int he H.10 statistical release of the Federal Reserve Board on March 13, 2026.

4. A total of 196,000 stock options granted on April 26, 2024 and vesting in three tranches: (i) 58,800 vested on April 26, 2025 and expiring on April 25, 2030, (ii) 58,800 vesting on April 26, 2026 and lapsing on April 25, 2031, and (iii) 78,400 vesting on April 26, 2027 and expiring on April 25, 2032.

5. A total of 231,000 stock options granted on April 21, 2023 and vesting in three tranches: (i) 69,300 vested on April 21, 2024 and expiring on April 20, 2029, (ii) 69,300 vested on April 21, 2025 and expiring on April 20, 2030, and (iii) 92,400 vesting on April 21, 2026 and expiring on April 20, 2031.

6. A total of 249,100 stock options granted on April 23, 2022 and vesting in three tranches: (i) 74,730 vested on April 23, 2023 and expiring on April 22, 2028, (ii) 74,730 vested on April 23, 2024 and expiring on April 22, 2029, and (iii) 99,640 vested on April 23, 2025 and expiring on April 22, 2030.

7. A total of 305,350 stock options granted on April 24, 2021 and vesting in three tranches: (i) 91,605 vested on April 24, 2022 and expiring on April 23, 2027, (ii) 91,605 vested on April 24, 2023 and expiring on April 23, 2028, and (iii) 122,140 vested on April 24, 2024 and expiring on April 23, 2029.

8. A total of 610,500 stock options granted on May 9, 2020 and vesting in three tranches: (i) 183,150 vested on May 9, 2021 and expiring on May 8, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 183,150 vested on May 9, 2022 and expiring on May 8, 2027, and (iii) 244,200 vested on May 9, 2023 and expiring on May 8, 2028.

9. A total of 449,500 stock options granted on May 6, 2019 and vesting in three tranches: (i) 134,850 vested on May 6, 2020 and expired on May 5, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 134,850 vested on May 6, 2021 and expiring on May 5, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 179,800 vested on May 6, 2022 and expiring on May 5, 2027.

10. A total of 202,125 stock options granted on May 3, 2017 and vesting in three tranches: (i) 60,638 vested on May 3, 2018 and expiring on May 2, 2028, (ii) 60,637 vested on May 3, 2019 and expiring on May 2, 2029, and (iii) 80,850 vested on May 3, 2020 and expiring on May 2, 2030.

11. A total of 256,025 stock options granted on April 28, 2016 and vesting in three tranches: (i) 76,808 vested on April 28, 2017 and expiring on April 27, 2027, (ii) 76,807 vested on April 28, 2018 and expiring on April 27, 2028, and (iii) 102,410 vested on April 28, 2019 and expiring on April 27, 2029.

12. A total of 404,250 stock options granted on September 16, 2015 and vesting in two tranches: (i) 202,125 vested on April 30, 2018 and expiring on April 29, 2028 and (ii) 202,125 vested on April 30, 2019 and expiring on April 29, 2029.

13. A total of 269,500 stock options granted on April 27, 2015 and vesting in three tranches: (i) 80,850 vested on April 27, 2016 and expiring on April 26, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 80,850 vested on April 27, 2017 and expiring on April 26, 2027, and (iii) 107,800 vested on April 27, 2018 and expiring on April 26, 2028.

14. A total of 269,500 stock options granted on April 25, 2014 and vesting in three tranches: (i) 80,850 vested on April 25, 2015 and expired on April 24, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 80,850 vested on April 25, 2016 and expiring on April 24, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 107,800 vested on April 25, 2017 and expiring on April 24, 2027.

15. A total of 233,750 stock options granted on April 26, 2013 and vesting in four tranches: (i) 46,750 vested on April 26, 2014 and expired on April 25, 2024 which have been fully exercised by the Reporting Person prior to expiration, (ii) 46,750 vested on April 26, 2015 and expired on April 25, 2025, which have been fully exercised by the Reporting Person prior to expiration, (iii) 70,125 vested on April 26, 2016 and expiring on April 25, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iv) 70,125 vested on April 26, 2017 and expiring on April 25, 2027.

Remarks:

Exhibit 24.1. See power of attorney attached

	/s/ Vivek Ranjan, as Attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Batra Sandeep